Xilio Therapeutics logo

Xilio Therapeutics Share Price Today

(NASDAQ: XLO)

Xilio Therapeutics share price is $0.91 & ₹79.14 as on 6 Mar 2025, 2.30 'hrs' IST

$0.91

0.05

(5.97%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Xilio Therapeutics share price in Dollar and Rupees. Guide to invest in Xilio Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xilio Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Xilio Therapeutics share price movements

  • Today's Low: $0.85
    Today's High: $0.93

    Day's Volatility :8.98%

  • 52 Weeks Low: $0.58
    52 Weeks High: $1.93

    52 Weeks Volatility :69.95%

Xilio Therapeutics (XLO) Returns

PeriodXilio Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-18.27%
2.1%
0.0%
6 Months
10.99%
-4.1%
0.0%
1 Year
4.66%
2.2%
0.0%
3 Years
-87.93%
11.8%
-11.6%

Xilio Therapeutics (XLO) Key Statistics

in dollars & INR

Previous Close
$0.8582
Open
$0.85
Today's High
$0.9339
Today's Low
$0.85
Market Capitalization
$43.0M
Today's Volume
$17.6K
52 Week High
$1.93
52 Week Low
$0.58
Revenue TTM
$4.6M
EBITDA
$-62.4M
Earnings Per Share (EPS)
$-1.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-170.96%

How to invest in Xilio Therapeutics Stock (XLO) from India?

It is very easy for Indian residents to invest directly in Xilio Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xilio Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xilio Therapeutics or XLO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xilio Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xilio Therapeutics shares which would translate to 0.956 fractional shares of Xilio Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xilio Therapeutics, in just a few clicks!

Returns in Xilio Therapeutics (XLO) for Indian investors in Rupees

The Xilio Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xilio Therapeutics investment value today

Current value as on today

₹1,15,938

Returns

₹15,938

(+15.94%)

Returns from Xilio Therapeutics Stock

₹10,976 (+10.98%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Xilio Therapeutics (XLO)

1544.44%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Xilio Therapeutics Shares from India has grown by 1544.44% over the past 30 days, indicating increased transactional activity.

1720%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Xilio Therapeutics Stock from India on INDmoney has increased by 1720% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Xilio Therapeutics

  • Bain Capital Life Sciences Investors, LLC

    9.12%

  • Rock Springs Capital Management LP

    6.00%

  • RiverVest Venture Management LLC

    2.88%

  • FMR Inc

    2.79%

  • Morgan Stanley - Brokerage Accounts

    2.00%

  • Vanguard Group Inc

    1.80%

Analyst Recommendation on Xilio Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Xilio Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Xilio Therapeutics Stock (XLO)

What analysts predicted

Upside of 394.51%

Target:

$4.50

Current:

$0.91

Insights on Xilio Therapeutics Stock (Ticker Symbol: XLO)

  • Price Movement

    In the last 1 month, XLO stock has moved up by 23.9%
  • XLO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 54.2%
  • XLO vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 137.7%
  • Price to Sales

    ForXLO every $1 of sales, investors are willing to pay $8.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Xilio Therapeutics Technicals Summary

Sell

Neutral

Buy

Xilio Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Xilio Therapeutics (XLO) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Xilio Therapeutics, Inc. logo
24.02%
10.99%
4.66%
-87.93%
-94.64%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Xilio Therapeutics, Inc. logo
NA
NA
NA
-1.21
-1.71
-0.53
NA
0.48
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Xilio Therapeutics, Inc. logo
Buy
$43.0M
-94.64%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Xilio Therapeutics

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Organization
Xilio Therapeutics
Employees
73
CEO
Dr. Rene Russo BCPS, Pharm.D.
Industry
Services

Management People of Xilio Therapeutics

NameTitle
Dr. Rene Russo BCPS, Pharm.D.
President, CEO & Director
Mr. Christopher Frankenfield
Chief Operating Officer
Dr. Katarina Luptakova M.D.
Chief Medical Officer
Mr. Kevin M. Brennan
Senior VP of Finance & Accounting
Dr. Uli Bialucha Ph.D.
Chief Scientific Officer
Ms. Caroline Hensley
Chief Legal Officer
Dr. Scott Coleman Ph.D.
Chief Development Officer

Important FAQs about investing in XLO Stock from India :

What is Xilio Therapeutics share price today?

Xilio Therapeutics share price today stands at $0.91, Open: $0.85 ; Previous Close: $0.86 ; High: $0.93 ; Low: $0.85 ; 52 Week High: $1.93 ; 52 Week Low: $0.58.

The stock opens at $0.85, after a previous close of $0.86. The stock reached a daily high of $0.93 and a low of $0.85, with a 52-week high of $1.93 and a 52-week low of $0.58.

Can Indians buy Xilio Therapeutics shares?

Yes, Indians can invest in the Xilio Therapeutics (XLO) from India.

With INDmoney, you can buy Xilio Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Xilio Therapeutics at zero transaction cost.

How can I buy Xilio Therapeutics shares from India?

It is very easy to buy Xilio Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xilio Therapeutics (XLO) be purchased?

Yes, you can buy fractional shares of Xilio Therapeutics with INDmoney app.

What are the documents required to start investing in Xilio Therapeutics stocks?

To start investing in Xilio Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Xilio Therapeutics Stock (XLO)?

Today’s highest price of Xilio Therapeutics (XLO) is $0.93.

Today’s lowest price of Xilio Therapeutics (XLO) is $0.85.

What is today's market capitalisation of Xilio Therapeutics?

Today's market capitalisation of Xilio Therapeutics XLO is 43.0M

What is the 52 Week High and Low Range of Xilio Therapeutics Stock (XLO)?

  • 52 Week High

    $1.93

  • 52 Week Low

    $0.58

What are the historical returns of Xilio Therapeutics (XLO)?

  • 1 Month Returns

    24.02%

  • 3 Months Returns

    10.99%

  • 1 Year Returns

    4.66%

  • 5 Years Returns

    -94.64%

Who is the Chief Executive Officer (CEO) of Xilio Therapeutics ?

Dr. Rene Russo BCPS, Pharm.D. is the current Chief Executive Officer (CEO) of Xilio Therapeutics.